Latest Breaking News On - Late breaking research - Page 7 : comparemela.com

Sapience Therapeutics to Present Late-Breaking Data on ST101 and ST316 at the American Association for Cancer Research (AACR) Annual Meeting 2023

Sapience Therapeutics to Present Late-Breaking Data on ST101 and ST316 at the American Association for Cancer Research (AACR) Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAmy conradBarry kappelAmerican association for cancer researchSapience therapeutics incEuropean commissionDrug administrationPrnewswire sapience therapeutics incAmerican associationCancer researchAnnual meetingLate breaking researchMolecular therapeuticsPoster sectionPresentation numberFast track

Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting

/PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid.

United statesSan diegoIgnacio guerrero rosDavid schullMike moyerAmerican association for cancer researchClinical researchCompany current reports on formCompany quarterly reports on formGlobal coalition for adaptive researchCompany annual report on formNational cancer institutePrnewswire kintara therapeutics incCancer researchAnnual meetingLate breaking research

Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAadi biosciencesMarcy grahamAadi bioscienceClinical researchCompany annual report on formPrnewswire aadi bioscience incAmerican association for cancer research annual meetingClinical research excluding trialsAadi bioscience incCancer research annual meetingClinical research excludingCombination therapiesLate breaking researchForward looking statementsPrivate securities litigation reform act

Demonstration of Accurate Screening of Gene Dependency in Multiple Myeloma from Aitia s Gemini Digital Twins to be Presented at 2023 AACR Annual Meeting

/PRNewswire/ Aitia, the leader in the application of causal AI and "Digital Twins" to discover and develop new drugs, announced today that data from its.

United statesPrnewswire aitiaZena sfeirAmerican association for cancer researchMyeloma research foundationMultiple myeloma digital twinAmerican associationCancer researchAnnual meetingMultiple myeloma research foundationLate breaking researchComputational biologySystems biologyConvergent scienceTuesday aprPoster section

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision.

United statesAadi biosciencesPrnewswire aadi bioscience incClinical research excluding trialsCompany annual report on formAmerican association for cancer research annual meetingAadi bioscience incClinical researchAmerican associationCancer research annual meetingClinical research excludingPoster combination therapiesLate breaking researchAadi bioscienceForward looking statementsPrivate securities litigation reform act